CA2299909A1 - Agent therapeutique pour troubles neurodegeneratifs - Google Patents

Agent therapeutique pour troubles neurodegeneratifs Download PDF

Info

Publication number
CA2299909A1
CA2299909A1 CA002299909A CA2299909A CA2299909A1 CA 2299909 A1 CA2299909 A1 CA 2299909A1 CA 002299909 A CA002299909 A CA 002299909A CA 2299909 A CA2299909 A CA 2299909A CA 2299909 A1 CA2299909 A1 CA 2299909A1
Authority
CA
Canada
Prior art keywords
therapeutic agent
neurodegenerative disorders
formula
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002299909A
Other languages
English (en)
Other versions
CA2299909C (fr
Inventor
Junichi Shimada
Masako Kurokawa
Ken Ikeda
Fumio Suzuki
Yoshihisa Kuwana
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Priority to CA002299909A priority Critical patent/CA2299909C/fr
Publication of CA2299909A1 publication Critical patent/CA2299909A1/fr
Application granted granted Critical
Publication of CA2299909C publication Critical patent/CA2299909C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002299909A 2000-03-02 2000-03-02 Agent therapeutique pour troubles neurodegeneratifs Expired - Fee Related CA2299909C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002299909A CA2299909C (fr) 2000-03-02 2000-03-02 Agent therapeutique pour troubles neurodegeneratifs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002299909A CA2299909C (fr) 2000-03-02 2000-03-02 Agent therapeutique pour troubles neurodegeneratifs

Publications (2)

Publication Number Publication Date
CA2299909A1 true CA2299909A1 (fr) 2001-09-02
CA2299909C CA2299909C (fr) 2008-05-13

Family

ID=4165430

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002299909A Expired - Fee Related CA2299909C (fr) 2000-03-02 2000-03-02 Agent therapeutique pour troubles neurodegeneratifs

Country Status (1)

Country Link
CA (1) CA2299909C (fr)

Also Published As

Publication number Publication date
CA2299909C (fr) 2008-05-13

Similar Documents

Publication Publication Date Title
WO2003037860A3 (fr) Analogues de purine presentant une activite inhibitrice de hsp90
IL157254A0 (en) N-substituted nonaryl-heterocyclic nmda/mr2b antagonists
ZA95631B (en) Prolineamide derivatives
WO2001072728A3 (fr) Nouveaux derives de piperazine
WO2000003997A1 (fr) Derives de thiobenzimidazole
HK1076816A1 (fr)
EP0630898A4 (fr) Remede contre la thrombopenie.
EP1666041A3 (fr) Derivés de la xanthine contre désordres neurodégénératifs
WO2001095856A3 (fr) Derive d'uree en tant qu'agent anticancereux et son procede de preparation
CA2455539A1 (fr) Promoteurs de la croissance chez le porc et procede pour promouvoir la croissance chez le porc
CA2369947A1 (fr) Derive d'acide hydroxamique
CA2386813A1 (fr) Derives d'imidazo-3-yl-amine bicycliques substitues sur le sixieme chainon
WO2002032901A3 (fr) Derives de piperazine pontes
CA2393757A1 (fr) Antagonistes du recepteur ccr5 de la cycloamine
WO2003024933A1 (fr) Derive d'acide 2-phenyle-3-heteroarylpropionique ou son sel et medicaments le contenant
CA2494321A1 (fr) Derive de 1,2,4-triazole, son procede de preparation et composition pharmaceutique le contenant
CA2263353A1 (fr) Derives d'arylsulfonylimidazoline agissant en tant qu'agents anti-tumoraux
EP1026162A4 (fr) Agent anti-rhumatismal
EP1191022A4 (fr) Derive de la dihydropyridine
WO2004048381A3 (fr) Nouveaux composes de pyrazoloazepine utilises en tant qu'agents pharmaceutiques
CA2299909A1 (fr) Agent therapeutique pour troubles neurodegeneratifs
WO2002004012A8 (fr) Composition pharmaceutique anhydre de vancomycine a usage topique
EP0759297A4 (fr) Remede pour le c ur droit
WO2005035528A3 (fr) Nouveaux composes triazoliques, leur procede de preparation et compositions pharmaceutiques les contenant
CA2353956A1 (fr) Agent therapeutique pour le traitement de la dyserection

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed